Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma-Reference-Cited by-同舟云学术

Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma

Published:2016-07-11 Issue:11 Volume:63 Page:2050-2053
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Steineck Angela¹,MacKenzie John D.²,Twist Clare J.³

Affiliation:

1. Department of Pediatrics; Stanford University School of Medicine; Stanford California

2. Department of Radiology; University of California at San Francisco; San Francisco California

3. Department of Pediatrics; Division of Hematology/Oncology; Stanford University School of Medicine; Stanford California

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference20 articles.

1. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med.,1999

2. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study;Matthay;J Clin Oncol.,2009

3. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med.,2010

4. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation;Ponzoni;Cancer Res.,1995

5. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma;Reynolds;Curr Oncol Rep.,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of systemic administration of the retinoid Isotretinoin on bone tissue: A narrative literature review;AIMS Bioengineering;2024

2. Impact of Childhood Cancer on Growth;The Journal of Clinical Endocrinology & Metabolism;2023-08-04

3. Potential Effects of Oral Isotretinoin on Growth Plate and Height;Endocrines;2023-04-07

4. Reduction of New Heterotopic Ossification ( HO ) in the Open‐Label , Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva ( FOP );Journal of Bone and Mineral Research;2023-01-25

5. Late effects in survivors of high‐risk neuroblastoma following stem cell transplant with and without total body irradiation;Pediatric Blood & Cancer;2021-12-31